297 related articles for article (PubMed ID: 34491058)
1. Effects of All-Atom Molecular Mechanics Force Fields on Amyloid Peptide Assembly: The Case of PHF6 Peptide of Tau Protein.
Man VH; He X; Gao J; Wang J
J Chem Theory Comput; 2021 Oct; 17(10):6458-6471. PubMed ID: 34491058
[TBL] [Abstract][Full Text] [Related]
2. Effects of All-Atom Molecular Mechanics Force Fields on Amyloid Peptide Assembly: The Case of Aβ
Man VH; He X; Derreumaux P; Ji B; Xie XQ; Nguyen PH; Wang J
J Chem Theory Comput; 2019 Feb; 15(2):1440-1452. PubMed ID: 30633867
[TBL] [Abstract][Full Text] [Related]
3. Structural insights into the co-aggregation of Aβ and tau amyloid core peptides: Revealing potential pathological heterooligomers by simulations.
Li X; Chen Y; Yang Z; Zhang S; Wei G; Zhang L
Int J Biol Macromol; 2024 Jan; 254(Pt 2):127841. PubMed ID: 37924907
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the force fields on monomeric and fibrillar PHF6 of tau protein.
Li Y; Peng X
Biophys Chem; 2021 Oct; 277():106631. PubMed ID: 34116358
[TBL] [Abstract][Full Text] [Related]
5. Different Force Fields Give Rise to Different Amyloid Aggregation Pathways in Molecular Dynamics Simulations.
Samantray S; Yin F; Kav B; Strodel B
J Chem Inf Model; 2020 Dec; 60(12):6462-6475. PubMed ID: 33174726
[TBL] [Abstract][Full Text] [Related]
6. Deciphering the Inhibitory Mechanism of Naphthoquinone-Dopamine on the Aggregation of Tau Core Fragments PHF6* and PHF6.
Zou Y; Qi B; Tan J; Guan L; Zhang Q; Sun Y; Huang F
ACS Chem Neurosci; 2023 Sep; 14(17):3265-3277. PubMed ID: 37585669
[TBL] [Abstract][Full Text] [Related]
7. Mechanistic insight into E22Q-mutation-induced antiparallel-to-parallel β-sheet transition of Aβ
Li X; Lei J; Qi R; Xie L; Wei G
Phys Chem Chem Phys; 2019 Jul; 21(28):15686-15694. PubMed ID: 31271401
[TBL] [Abstract][Full Text] [Related]
8. Disclosing the Mechanism of Spontaneous Aggregation and Template-Induced Misfolding of the Key Hexapeptide (PHF6) of Tau Protein Based on Molecular Dynamics Simulation.
Liu H; Zhong H; Liu X; Zhou S; Tan S; Liu H; Yao X
ACS Chem Neurosci; 2019 Dec; 10(12):4810-4823. PubMed ID: 31661961
[TBL] [Abstract][Full Text] [Related]
9. Effects of ion type and concentration on the structure and aggregation of the amyloid peptide A
Smorodina E; Kav B; Fatafta H; Strodel B
Proteins; 2023 Nov; ():. PubMed ID: 37964477
[TBL] [Abstract][Full Text] [Related]
10. Development of a Hybrid-Resolution Force Field for Peptide Self-Assembly Simulations: Optimizing Peptide-Peptide and Peptide-Solvent Interactions.
Cai X; Han W
J Chem Inf Model; 2022 Jun; 62(11):2744-2760. PubMed ID: 35561002
[TBL] [Abstract][Full Text] [Related]
11. Atomistic Insights into the Inhibitory Mechanism of Tyrosine Phosphorylation against the Aggregation of Human Tau Fragment PHF6.
Zou Y; Guan L; Tan J; Qi B; Wang Y; Zhang Q; Sun Y
J Phys Chem B; 2023 Jan; 127(1):335-345. PubMed ID: 36594671
[TBL] [Abstract][Full Text] [Related]
12. Evolution of large Aβ16-22 aggregates at atomic details and potential of mean force associated to peptide unbinding and fragmentation events.
Iorio A; Timr Š; Chiodo L; Derreumaux P; Sterpone F
Proteins; 2023 Aug; 91(8):1152-1162. PubMed ID: 37139594
[TBL] [Abstract][Full Text] [Related]
13. Primary Fibril Nucleation of Aggregation Prone Tau Fragments PHF6 and PHF6.
Smit FX; Luiken JA; Bolhuis PG
J Phys Chem B; 2017 Apr; 121(15):3250-3261. PubMed ID: 27776213
[TBL] [Abstract][Full Text] [Related]
14. Integrating in vitro and in silico approaches to evaluate the "dual functionality" of palmatine chloride in inhibiting and disassembling Tau-derived VQIVYK peptide fibrils.
Haj E; Losev Y; Guru KrishnaKumar V; Pichinuk E; Engel H; Raveh A; Gazit E; Segal D
Biochim Biophys Acta Gen Subj; 2018 Jul; 1862(7):1565-1575. PubMed ID: 29634991
[TBL] [Abstract][Full Text] [Related]
15. Terminal Capping of an Amyloidogenic Tau Fragment Modulates Its Fibrillation Propensity.
Arya S; Ganguly P; Arsiccio A; Claud SL; Trapp B; Schonfeld GE; Liu X; Lazar Cantrell K; Shea JE; Bowers MT
J Phys Chem B; 2020 Oct; 124(40):8772-8783. PubMed ID: 32816481
[TBL] [Abstract][Full Text] [Related]
16. Identification of Aggregation Mechanism of Acetylated PHF6* and PHF6 Tau Peptides Based on Molecular Dynamics Simulations and Markov State Modeling.
Shah SJA; Zhang Q; Guo J; Liu H; Liu H; Villà-Freixa J
ACS Chem Neurosci; 2023 Nov; 14(21):3959-3971. PubMed ID: 37830541
[TBL] [Abstract][Full Text] [Related]
17. ATP Controls the Aggregation of Aβ
Pal S; Paul S
J Phys Chem B; 2020 Jan; 124(1):210-223. PubMed ID: 31830415
[TBL] [Abstract][Full Text] [Related]
18. Purpurin modulates Tau-derived VQIVYK fibrillization and ameliorates Alzheimer's disease-like symptoms in animal model.
Viswanathan GK; Shwartz D; Losev Y; Arad E; Shemesh C; Pichinuk E; Engel H; Raveh A; Jelinek R; Cooper I; Gosselet F; Gazit E; Segal D
Cell Mol Life Sci; 2020 Jul; 77(14):2795-2813. PubMed ID: 31562564
[TBL] [Abstract][Full Text] [Related]
19. On the Tracks of the Aggregation Mechanism of the PHF6 Peptide from Tau Protein: Molecular Dynamics, Energy, and Interaction Network Investigations.
Fagnen C; Giovannini J; Catto M; Voisin-Chiret AS; Sopkova-de Oliveira Santos J
ACS Chem Neurosci; 2022 Oct; 13(19):2874-2887. PubMed ID: 36153969
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of tau amyloid formation and disruption of its preformed fibrils by Naphthoquinone-Dopamine hybrid.
Paul A; Viswanathan GK; Huber A; Arad E; Engel H; Jelinek R; Gazit E; Segal D
FEBS J; 2021 Jul; 288(14):4267-4290. PubMed ID: 33523571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
